Tracon licensed the North American rights to envafolimab from China-based Jiangsu Alphamab Biopharmaceuticals and 3D Medicines in 2019. Image Credit: TarikVision / Shutterstock. TRACON Pharmaceuticals
Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to accelerate development of messenger RNA-based pandemic influenza vaccines, the company
The asset is intended to treat congenital adrenal hyperplasia in paediatric and adult patients. Credit: YURIMA / Shutterstock. The US Food and Drug Administration (FDA)
Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), today announced the acquisition of the
Optibrium, a leading developer of software and AI solutions for molecular design today announced the publication of a peer-reviewed study in Journal of Computer-Aided Molecular
Eisai’s Phase I/II trial is assessing the ADC for solid tumours. Credit: Kateryna Kon / Shutterstock. Eisai has announced the termination of its worldwide strategic
As part of its long-term plan launched in 2019, the UK’s National Health Service (NHS) preventative care mission aims to reduce health inequalities, lower healthcare
The effects of socioeconomic position and race on the link between closeness to urban green and blue areas and cardiovascular health.
Researchers examined the longitudinal association between exposure to electronic cigarette flavors and nocturnal dry cough.
The unilateral decision by Peter Marks, a top official at the Food and Drug Administration, to approve the gene therapy Elevidys, a treatment for Duchenne